Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marine Lemesle"'
Autor:
Marine Lemesle, Marine Geoffroy, Fabien Alpy, Catherine-Laure Tomasetto, Sandra Kuntz, Isabelle Grillier-Vuissoz
Publikováno v:
Cancers; Volume 14; Issue 20; Pages: 5026
Triple-negative breast cancer (TNBC) is an aggressive subtype that constitutes 15–20% of breast cancer cases worldwide. Current therapies often evolve into chemoresistance and lead to treatment failure. About 77% of the TNBC lacks claudin-1 (CLDN1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::000895cf8a8ad0f6d9e3ea29834044e9
Autor:
Marine Geoffroy, Marine Lemesle, Alexandra Kleinclauss, Sabine Mazerbourg, Levy Batista, Muriel Barberi-Heyob, Thierry Bastogne, Wilfrid Boireau, Alain Rouleau, Dorian Dupommier, Michel Boisbrun, Corinne Comoy, Stéphane Flament, Isabelle Grillier-Vuissoz, Sandra Kuntz
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2022, 23 (12), pp.6859. ⟨10.3390/ijms23126859⟩
International Journal of Molecular Sciences; Volume 23; Issue 12; Pages: 6859
International Journal of Molecular Sciences, 2022, 23 (12), pp.6859. ⟨10.3390/ijms23126859⟩
International Journal of Molecular Sciences; Volume 23; Issue 12; Pages: 6859
International audience; Breast cancer is one of the leading causes of cancer-related death among females worldwide. A major challenge is to develop innovative therapy in order to treat breast cancer subtypes resistant to current treatment. In the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd7c9c08564ae6e1f4e819996f0ed51
https://pubmed.ncbi.nlm.nih.gov/35743305
https://pubmed.ncbi.nlm.nih.gov/35743305